http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0725668-B2

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L15-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G18-61
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7069
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L15-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08G18-61
filingDate 1989-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1995-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H0725668-B2
titleOfInvention Matrix for transdermal drug release
priorityDate 1988-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420001625
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4946
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4100
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450159460
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23666729
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284466
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8907
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447740608
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419496561
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502129
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554785
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21712006
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419530439
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID162265
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504954
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID258030
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410508238
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6041

Total number of triples: 30.